Tissue‐specific methylomic responses to a lifestyle intervention in older adults associate with metabolic and physiological health improvements
Lucy Sinke,Marian Beekman,Yotam Raz,Thies Gehrmann,Ioannis Moustakas,Alexis Boulinguiez,Nico Lakenberg,Eka Suchiman,Fatih A. Bogaards,Daniele Bizzarri,Erik B. van den Akker,Melanie Waldenberger,Gillian Butler‐Browne,Capucine Trollet,C. P. G. M. de Groot,Bastiaan T. Heijmans,P. Eline Slagboom
DOI: https://doi.org/10.1111/acel.14431
IF: 11.005
2024-12-02
Aging Cell
Abstract:Diet and physical activity influence immunometabolic health across the lifespan, and DNA methylation may mediate a part of these effects. The Growing Old Together (GOTO) study, a 13‐week lifestyle intervention in older adults, revealed epigenetic changes in muscle, adipose, and blood at hundreds of CpGs, linking these to differential gene expression, health improvements, and finding that the intervention consistently decreased participants' biological age. Across the lifespan, diet and physical activity profiles substantially influence immunometabolic health. DNA methylation, as a tissue‐specific marker sensitive to behavioral change, may mediate these effects through modulation of transcription factor binding and subsequent gene expression. Despite this, few human studies have profiled DNA methylation and gene expression simultaneously in multiple tissues or examined how molecular levels react and interact in response to lifestyle changes. The Growing Old Together (GOTO) study is a 13‐week lifestyle intervention in older adults, which imparted health benefits to participants. Here, we characterize the DNA methylation response to this intervention at over 750 thousand CpGs in muscle, adipose, and blood. Differentially methylated sites are enriched for active chromatin states, located close to relevant transcription factor binding sites, and associated with changing expression of insulin sensitivity genes and health parameters. In addition, measures of biological age are consistently reduced, with decreases in grimAge associated with observed health improvements. Taken together, our results identify responsive molecular markers and demonstrate their potential to measure progression and finetune treatment of age‐related risks and diseases.
cell biology,geriatrics & gerontology